HEALTH ECONOMIC EVALUATION OF TICAGRELOR IN PATIENTS WITH ACUTE CORONARY PATIENTS (ACS) BASED ON THE PLATO STUDY FROM A SPANISH HEALTH CARE PERSPECTIVE

被引：1

作者：

Delgado-Ortega, L. ^{[1
]}

Lopez-Sendon, J. L. ^{[2
]}

Heras Fortuny, M. ^{[4
]}

Alvarez Sanz, C. ^{[1
]}

Nikolic, E. ^{[3
]}

Mellstrom, C. ^{[5
]}

Wallentin, L. ^{[6
]}

机构：

[1] Astrazeneca Spain, Madrid, Spain

[2] Hosp La Paz, Madrid, Spain

[3] Linkoping Univ, Linkoping, Sweden

[4] Hosp Clin Barcelona, Barcelona, Spain

[5] Astrazeneca R&D, Lomma, Sweden

[6] Uppsala Univ, Uppsala, Sweden

来源：

VALUE IN HEALTH | 2011年 / 14卷 / 07期

关键词：

D O I：

10.1016/j.jval.2011.08.766

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

引用

页码：A372 / A372

页数：1

共 50 条

[1] ECONOMIC EVALUATION OF CLOPIDOGREL VERSUS TICAGRELOR, IN PATIENTS WITH ACUTE CORONARY SYNDROME, FROM THE PERSPECTIVE OF THE MEXICAN PUBLIC HEALTH CARE SYSTEM
Reyes-Lopez, A.
Camacho-Chairez, A.
Gonzalez-Diaz, B.
VALUE IN HEALTH, 2014, 17 (03) : A115 - A115
[2] LIFETIME COST-EFFECTIVENESS ANALYSIS OF TICAGRELOR IN PATIENTS WITH ACUTE CORONARY SYNDROMES BASED ON THE PLATO TRIAL: A SINGAPORE HEALTH CARE PERSPECTIVE
Chin, C. T.
Mellstroem, C.
Chua, T. S.
Matchar, D. B.
VALUE IN HEALTH, 2012, 15 (07) : A632 - A633
[3] LONG-TERM COST-EFFECTIVENESS ANALYSIS OF TICAGRELOR IN PATIENTS WITH ACUTE CORONARY SYNDROME (ACS) FROM A MEXICAN PUBLIC AND PRIVATE HEALTH CARE PERSPECTIVE BASED ON DATA FROM THE PLATO TRIAL
Garcia-Castillo, A.
De-los-Rios, M.
Polanco, A. C.
Ramirez, M. A.
Nikolic, E.
Mellstrom, C.
VALUE IN HEALTH, 2011, 14 (07) : A379 - A380
[4] LONG TERM COST-EFFECTIVENESS ANALYSIS OF TICAGRELOR IN PATIENTS WITH ACUTE CORONARY SYNDROMES FROM A TURKISH HEALTH CARE PERSPECTIVE BASED ON DATA FROM THE PLATO TRIAL
Abaci, A.
Bozkurt, E.
Mellstrom, C.
Caglayan, B.
VALUE IN HEALTH, 2012, 15 (07) : A370 - A370
[5] Health economic evaluation of ticagrelor compared to generic clopidogrel in patients with acute coronary syndromes intended for non-invasive management based on the PLATO trial
James, S.
Storey, R. F.
Cannon, C.
Janzon, M.
Nicolau, J. C.
Parasuraman, B.
Mellstrom, K.
Wallentin, L.
Henriksson, M.
EUROPEAN HEART JOURNAL, 2013, 34 : 896 - 896
[6] LONG-TERM COST EFFECTIVENESS ANALYSIS OF TICAGRELOR IN PATIENTS WITH ACUTE CORONARY SYNDROME FROM A POLISH HEALTH CARE PERSPECTIVE
Macioch, T.
Niewada, M.
Perkowski, P.
Mellstroem, C.
Budaj, A.
VALUE IN HEALTH, 2011, 14 (07) : A377 - A377
[7] Economic analysis of the use of clopidogrel in patients with acute coronary syndrome without ST segment elevation (ACS) from the Russian health care system perspective
Belousov, YB
Lazebnik, LB
Bykov, AV
Nguyen, T
Spiesser, J
VALUE IN HEALTH, 2003, 6 (06) : 663 - 663
[8] FOLLOW-ON HEALTH CARE COSTS IN PATIENTS WITH ACUTE CORONARY SYNDROME (ACS)
Berger, A.
LaPensee, K.
Oster, G.
VALUE IN HEALTH, 2013, 16 (07) : A521 - A522
[9] TICAGRELOR FOR THE TREATMENT OF ACUTE CORONARY SYNDROMES (ACS): A DUTCH ANALYSIS BASED ON THE PLATO TRIAL
Thurston, S.
Heeg, B.
Hofste, C.
VALUE IN HEALTH, 2011, 14 (07) : A380 - A380
[10] ECONOMIC EVALUATION OF TICAGRELOR VERSUS CLOPIDOGREL IN CANADIAN PATIENTS WITH ACUTE CORONARY SYNDROMES BASED ON THE PLATELET INHIBITION AND PATIENT OUTCOMES (PLATO) TRIAL
Bainey, K. R.
Grima, D. T.
Brown, S. T.
Kamboj, L.
Goeree, R.
Oh, P.
Ramanathan, K.
Goodman, S. G.
CANADIAN JOURNAL OF CARDIOLOGY, 2013, 29 (10) : S299 - S299

← 1 2 3 4 5 →